As a leading international translation provider, life science translation is one of our core services. We specialize in translation in the fields of pharmaceuticals, biotechnology, medical devices, and healthcare, we handle a wide range of materials—from clinical trial reports (CTDs, IBs) and regulatory submissions (FDA, EMA, NMPA dossiers) to patient safety documents, drug labels, and academic research. Our translation team comprises translators with advanced degrees in biology, chemistry, pharmacology, or medical sciences, combined with expertise in global regulatory frameworks (ICH guidelines, GCP, ISO 13485). We understand that in life sciences, precision isn’t just a standard—it’s a matter of compliance, patient safety, and market viability.

Regulatory Compliance & Market Access: 

Accurate translation is non-negotiable for global drug approvals or device registrations. Mistranslations in efficacy data, adverse event reports, or dosage instructions can delay submissions, violate regulations, or compromise patient safety. Our translations ensure alignment with strict requirements of agencies like the FDA (US), EMA (EU), or PMDA (Japan), enabling seamless market entry.

Scientific Precision: 

Life sciences terminology is highly specialized—terms like “pharmacokinetics,” “monoclonal antibody,” or “placebo effect” demand exacting accuracy. We preserve the technical integrity of complex concepts (e.g., genetic sequences, formulation specifications, or clinical trial methodologies) to avoid misinterpretation in research, manufacturing, or patient care.

Global Patient Safety & Trust: 

Translating patient-facing materials (informed consent forms, user manuals, drug labels) into local languages ensures clarity and adherence to cultural healthcare norms. This builds trust, minimizes risks of misuse.